1. Home
  2. CYTK vs TX Comparison

CYTK vs TX Comparison

Compare CYTK & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

TX

Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

HOLD

Current Price

$41.98

Market Cap

7.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
TX
Founded
1997
1961
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Steel/Iron Ore
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.3B
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
CYTK
TX
Price
$63.34
$41.98
Analyst Decision
Strong Buy
Buy
Analyst Count
16
6
Target Price
$84.81
$37.08
AVG Volume (30 Days)
1.8M
217.4K
Earning Date
02-26-2026
02-17-2026
Dividend Yield
N/A
6.45%
EPS Growth
N/A
635.85
EPS
N/A
2.97
Revenue
$87,211,000.00
$15,710,564,000.00
Revenue This Year
$341.94
N/A
Revenue Next Year
$75.44
$7.22
P/E Ratio
N/A
$14.07
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$24.00
52 Week High
$70.98
$44.16

Technical Indicators

Market Signals
Indicator
CYTK
TX
Relative Strength Index (RSI) 49.19 54.42
Support Level $62.13 $42.22
Resistance Level $65.88 $44.16
Average True Range (ATR) 2.59 1.03
MACD 0.07 -0.06
Stochastic Oscillator 54.84 46.12

Price Performance

Historical Comparison
CYTK
TX

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.

Share on Social Networks: